NBIX icon

Neurocrine Biosciences
NBIX

Overview Fund Activity

218 hedge funds and large institutions have $3.68B invested in Neurocrine Biosciences in 2017 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 72 increasing their positions, 80 reducing their positions, and 37 closing their positions.

Holders
218
Holders Change
-7
Holders Change %
-3.11%
% of All Funds
5.44%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.15%
New
38
Increased
72
Reduced
80
Closed
37
Calls
$12.3M
Puts
$20.3M
Net Calls
-$8.01M
Net Calls Change
-$6.53M

Top Buyers

1
BlackRock
1
BlackRock
New York
$218M
2
Wellington Management Group
2
Wellington Management Group
Massachusetts
$104M
3
JHIU
3
Janus Henderson Investors US
Colorado
$189M
4
Goldman Sachs
4
Goldman Sachs
New York
$75.5M
5
MWNA
5
Marshall Wace North America
New York
$34.9M

Top Sellers

1
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$178M
2
O
2
OrbiMed
New York
$19.1M
3
Millennium Management
3
Millennium Management
New York
$0
4
Fidelity Investments
4
Fidelity Investments
Massachusetts
$521M
5
Alyeska Investment Group
5
Alyeska Investment Group
Illinois
$1.42M
Name Market Value Shares Shares
Change 		Shares
Change %
Fidelity Investments
1
Fidelity Investments
Massachusetts
$521M 12,030,149 -919,926 -7%
Vanguard Group
2
Vanguard Group
Pennsylvania
$292M 6,735,965 +293,755 +5%
BlackRock
3
BlackRock
New York
$218M 5,031,933 +4,996,784 +14,216%
JHIU
4
Janus Henderson Investors US
Colorado
$189M 4,359,384 +2,002,899 +85%
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$178M 4,112,746 -1,867,417 -31%
PA
6
Perceptive Advisors
New York
$146M 3,366,530 +50,007 +2%
BB
7
BB Biotech
Switzerland
$139M 3,201,552 +50,000 +2%
Franklin Resources
8
Franklin Resources
California
$121M 2,798,715 +389,000 +16%
Invesco
9
Invesco
Georgia
$118M 2,721,064 -60,359 -2%
State Street
10
State Street
Massachusetts
$112M 2,579,055 +289,884 +13%
Wellington Management Group
11
Wellington Management Group
Massachusetts
$104M 2,407,376 +2,039,509 +554%
Bank of New York Mellon
12
Bank of New York Mellon
New York
$82.5M 1,906,417 +505,604 +36%
Goldman Sachs
13
Goldman Sachs
New York
$75.5M 1,743,949 +997,434 +134%
HM
14
HealthCor Management
New York
$53M 1,225,000 +236,100 +24%
Westfield Capital Management
15
Westfield Capital Management
Massachusetts
$51.3M 1,185,483 -208,022 -15%
PAMU
16
Pictet Asset Management (UK)
United Kingdom
$44M 1,015,894 +234,157 +30%
ACH
17
ArrowMark Colorado Holdings
Colorado
$43.6M 1,006,998 +115,471 +13%
Citadel Advisors
18
Citadel Advisors
Florida
$42.4M 978,532 +717,664 +275%
AllianceBernstein
19
AllianceBernstein
Tennessee
$40.2M 928,015 -95,427 -9%
SIG
20
Senator Investment Group
New York
$39M 900,000 +25,000 +3%
BBA
21
Baker Bros. Advisors
New York
$38.8M 895,422 – –
Deutsche Bank
22
Deutsche Bank
Germany
$38.4M 887,734 +39,549 +5%
Capital World Investors
23
Capital World Investors
California
$37.4M 863,000 -325,000 -27%
SAM
24
Sectoral Asset Management
Quebec, Canada
$36.8M 851,019 +102,031 +14%
JPMorgan Chase & Co
25
JPMorgan Chase & Co
New York
$35.1M 809,711 -153,034 -16%
1
2 3 4 5